Title : Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease - Riley_2009_IDrugs_12_648 |
Author(s) : Riley RF , Corson MA |
Ref : IDrugs , 12 :648 , 2009 |
Abstract : Riley_2009_IDrugs_12_648 |
ESTHER : Riley_2009_IDrugs_12_648 |
PubMedSearch : Riley_2009_IDrugs_12_648 |
PubMedID: 19790016 |
Riley RF, Corson MA (2009)
Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease
IDrugs
12 :648
Riley RF, Corson MA (2009)
IDrugs
12 :648